Home › Funds › Atlas Venture Life Science Advisors, LLC › IRON

Atlas Venture Life Science Advisors, LLC position in IRON

DISC MEDICINE INC · Health Care

Atlas Venture Life Science Advisors, LLC reported holding 1,384,025 shares of IRON (DISC MEDICINE INC) in its Q3 2026 13F filing — a position valued at US$90.6M, representing 14.35% of its reported portfolio and ranking #2 among its reported holdings. Atlas Venture Life Science Advisors, LLC has disclosed IRON holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.38M sh
Reported value held$90.60M
Portfolio Weight14.35%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Atlas Venture Life Science Advisors, LLC's IRON position evolved

Atlas Venture Life Science Advisors, LLC first disclosed a stake in IRON in Q3 2023 at 2,745,335 shares (US$129.0M). The position peaked in Q4 2024 at 2,509,456 shares, worth US$159.1M. Across 13 filings, Atlas Venture Life Science Advisors, LLC increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 1,384,025 shares valued at US$90.6M — a reduction of -129,850 shares quarter over quarter.. Notable position changes include a 29% trim in Q4 2025 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.75M $128.98M New
Q4 2023 2.56M $147.59M Reduce
Q1 2024 2.29M $142.40M Reduce
Q2 2024 2.51M $113.10M Add
Q3 2024 2.51M $123.31M Hold
Q4 2024 2.51M $159.10M Hold
Q1 2025 2.38M $118.36M Reduce
Q2 2025 2.38M $126.28M Hold
Q3 2025 2.14M $141.58M Reduce
Q4 2025 1.51M $120.22M Reduce
Q1 2026 1.51M $96.80M Hold
Q2 2026 1.51M $110.72M Hold
Q3 2026 1.38M $90.60M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRON and 13F data

IRON (DISC MEDICINE INC) is a Health Care company. 37 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Frazier Life Sciences Management, L.P. (US$99.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRON

All IRON fund holders →

FAQ

How long has Atlas Venture Life Science Advisors, LLC held IRON?

Atlas Venture Life Science Advisors, LLC has disclosed IRON holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Atlas Venture Life Science Advisors, LLC's current position in IRON?

As of Q3 2026, Atlas Venture Life Science Advisors, LLC holds 1.38M shares of IRON (DISC MEDICINE INC), valued at $90.60M, representing 14.35% of its reported portfolio and ranking #2.

Has Atlas Venture Life Science Advisors, LLC been buying or selling IRON?

In the latest 13F filing (Q3 2026), Atlas Venture Life Science Advisors, LLC reduced its position in IRON. The position peaked in Q4 2024 at 2.51M shares.

Which other funds hold IRON?

Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Frazier Life Sciences Management, L.P., among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.